Intravitreal Injection of Ranibizumab for Treatment of Age-Related Macular Degeneration: Effects on Serum VEGF Concentration

Author： Gu Xiaoya Yu Xiaobing Dai Hong

Publisher： Informa Healthcare

ISSN： 0271-3683

Source： Current Eye Research, Vol.39, Iss.5, 2014-05, pp. : 518-521

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

VEGF Gene Polymorphism and Response to Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration

Ophthalmic Research, Vol. 51, Iss. 1, 2013-10 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Three-Year Visual Outcome and Injection Frequency of Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration

Ophthalmologica, Vol. 230, Iss. 1, 2013-04 ,pp. : 27-33

Karger

Access to resources Recommend Favorite

A Case of Sustained Intraocular Pressure Elevation after Multiple Intravitreal Injection of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration

Case Reports in Ophthalmology, Vol. 7, Iss. 1, 2016-04 ,pp. : 230-236

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Predominantly Hemorrhagic Choroidal Neovascularization in Age-Related Macular Degeneration

Ophthalmologica, Vol. 233, Iss. 2, 2015-01 ,pp. : 74-81

Karger

Access to resources Recommend Favorite